반응식
[NH2:1][C@H:2]1[CH2:8][CH2:7][CH2:6][CH2:5][NH:4][C:3]1=[O:9].Cl[C:11](OC1C=CC([N+]([O-])=O)=CC=1)=[O:12].[CH:23](N(C(C)C)CC)(C)C.[Cl:32][C:33]1[CH:42]=[C:41]2[C:36]([C:37]([N:44]3[CH2:49][CH2:48][NH:47][CH2:46][CH2:45]3)=[CH:38][C:39]([NH2:43])=[N:40]2)=[CH:35][CH:34]=1>>[Cl:32][C:33]1[CH:42]=[C:41]2[C:36]([C:37]([N:44]3[CH2:49][CH2:48][N:47]([C:11]([NH:1][C@H:2]4[CH2:8][CH2:7][CH2:6][CH2:5][NH:4][C:3]4=[O:9])=[O:12])[CH2:46][CH2:45]3)=[CH:38][C:39]([NH:43][CH3:23])=[N:40]2)=[CH:35][CH:34]=1참가 물질
5
실험 절차
As described for example 78, (3S)-3-aminohexahydro-2H-azepin-2-one, 4-nitrophenyl chloroformate, diisopropyl(ethyl)amine, and 7-chloro-4-(1-piperazinyl)-2-quinolinamine are reacted to afford the product as a light yellow solid. LC-MS: 431 (M++1). 1H NMR (CDCl3): δ 1.34˜1.60 (m, 2H), 1.80˜1.92 (m, 2H), 1.98˜2.08 (m, 1H), 2.10˜2.18 (m, 1H), 3.06 (d, 3H), 3.12 (br.s, 4H), 3.20˜3.38 (m, 2H), 3.67 (br.s, 4H), 4.52 (br. dd, 1H), 5.98˜6.06 (m, 2H), 6.12 (d, 1H), 7.12 (dd, 1H), 7.67 (d, 1H), 7.70 (d, 1H).
후처리
- customare reacted
출처 및 근거
- ORD 기록
- ord-eef42cbb1adf4db49cef4e32947f7b00
- 출처 데이터셋
- uspto-grants-2007_05
- 특허 번호
- US07220856B2
연결된 노트
불러오는 중…